1. Home
  2. LKFN vs SNDX Comparison

LKFN vs SNDX Comparison

Compare LKFN & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LKFN
  • SNDX
  • Stock Information
  • Founded
  • LKFN 1872
  • SNDX 2005
  • Country
  • LKFN United States
  • SNDX United States
  • Employees
  • LKFN N/A
  • SNDX N/A
  • Industry
  • LKFN Major Banks
  • SNDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LKFN Finance
  • SNDX Health Care
  • Exchange
  • LKFN Nasdaq
  • SNDX Nasdaq
  • Market Cap
  • LKFN 1.3B
  • SNDX 1.1B
  • IPO Year
  • LKFN 1997
  • SNDX 2016
  • Fundamental
  • Price
  • LKFN $60.90
  • SNDX $9.28
  • Analyst Decision
  • LKFN Buy
  • SNDX Strong Buy
  • Analyst Count
  • LKFN 2
  • SNDX 11
  • Target Price
  • LKFN $65.00
  • SNDX $35.91
  • AVG Volume (30 Days)
  • LKFN 234.3K
  • SNDX 2.5M
  • Earning Date
  • LKFN 04-25-2025
  • SNDX 05-05-2025
  • Dividend Yield
  • LKFN 3.27%
  • SNDX N/A
  • EPS Growth
  • LKFN N/A
  • SNDX N/A
  • EPS
  • LKFN 3.50
  • SNDX N/A
  • Revenue
  • LKFN $236,268,000.00
  • SNDX $43,722,000.00
  • Revenue This Year
  • LKFN $16.03
  • SNDX $274.51
  • Revenue Next Year
  • LKFN $4.31
  • SNDX $140.65
  • P/E Ratio
  • LKFN $17.56
  • SNDX N/A
  • Revenue Growth
  • LKFN N/A
  • SNDX N/A
  • 52 Week Low
  • LKFN $50.00
  • SNDX $9.66
  • 52 Week High
  • LKFN $78.61
  • SNDX $25.07
  • Technical
  • Relative Strength Index (RSI)
  • LKFN 63.29
  • SNDX 33.02
  • Support Level
  • LKFN $59.02
  • SNDX $9.67
  • Resistance Level
  • LKFN $62.34
  • SNDX $11.48
  • Average True Range (ATR)
  • LKFN 1.69
  • SNDX 1.00
  • MACD
  • LKFN 0.78
  • SNDX -0.34
  • Stochastic Oscillator
  • LKFN 88.33
  • SNDX 0.80

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. Lakeland offers a broad range of products and services throughout its Northern and Central Indiana markets. The company offers commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

Share on Social Networks: